Urgent

Atrial flutter (rapid)

Tachyarrhythmia · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A macro-reentrant atrial tachycardia — typical (cavotricuspid isthmus-dependent) flutter has an atrial rate of ~300/min with saw-tooth flutter waves (best seen in II, III, aVF), usually conducting 2:1 to give a ventricular rate of ~150/min. A regular narrow-complex tachycardia at ~150/min is flutter until proven otherwise. Stroke risk and anticoagulation are managed the same way as atrial fibrillation.

Red flags

  • Haemodynamic instability (shock, ischaemia, pulmonary oedema)
  • 1:1 conduction (very fast, e.g. with a class Ic drug or exertion) — can be dangerously rapid
  • New flutter with a precipitant (PE, thyrotoxicosis, sepsis)
  • Broad-complex flutter — exclude VT

Assessment

Differential diagnosis

  • Atrial fibrillation
  • Other SVT (AVNRT/AVRT, atrial tachycardia)
  • Sinus tachycardia
  • Ventricular tachycardia (if broad/aberrant)

Investigations

  • 12-lead ECG (look for saw-tooth flutter waves; a vagal manoeuvre or adenosine slows AV conduction and UNMASKS them — diagnostic, not therapeutic)
  • U&E, TFTs, consider PE/sepsis/ischaemia as precipitants
  • Assess CHA₂DS₂-VASc for anticoagulation

Management

  • If HAEMODYNAMICALLY UNSTABLE → synchronised DC cardioversion (flutter often converts with LOW energy, ~50 J).
  • If stable: rate control with a beta-blocker or rate-limiting calcium-channel blocker (flutter is often harder to rate-control than AF).
  • Rhythm control — chemical/electrical cardioversion — with the same anticoagulation/duration rules as AF (< 48 h, or anticoagulated/TOE-cleared).
  • Anticoagulate per CHA₂DS₂-VASc exactly as for atrial fibrillation.
  • Treat precipitants; refer for CAVOTRICUSPID ISTHMUS ABLATION, which is highly effective and often curative for typical flutter.

Drugs & doses

Synchronised DC cardioversion (low energy ~50 J) if unstable
Rate control: beta-blocker or diltiazem/verapamil
Anticoagulation per CHA₂DS₂-VASc (as for AF)
Adenosine to unmask flutter waves (diagnostic only — will not cardiovert flutter)

Disposition

Admit/observe per stability and precipitant; cardiology referral for ablation. Anticoagulate as for AF.

Complications & pitfalls

  • Thromboembolism / stroke
  • Tachycardia-mediated cardiomyopathy (chronic uncontrolled rate)
  • Haemodynamic decompensation with 1:1 conduction

Exam pearls

  • Regular narrow tachycardia at ~150/min = 2:1 atrial flutter until proven otherwise.
  • Adenosine/vagal manoeuvres unmask flutter waves but won’t terminate it — it’s diagnostic.
  • Anticoagulate exactly as for AF; isthmus ablation is often curative for typical flutter.
  • Flutter cardioverts with low energy (~50 J).

Suspect 2:1 atrial flutter in any regular narrow tachycardia at ~150/min — unmask flutter waves with a vagal manoeuvre/adenosine, DC cardiovert (low energy) if unstable, otherwise rate-control and manage rhythm and anticoagulation exactly as for AF, and refer for cavotricuspid isthmus ablation.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.